Speaker illustration

Doctor Stefano Righetti

San Gerardo Vecchio Hospital, Monza (Italy)

Endocavitary injection of bone-marrow-derived CD133+ cells in ischemic REfractory CARDIOmyopathy (RECARDIO trial)

Event: ESC Congress 2017

Topic: Stem cells and cell therapy

Session: Best Posters in stem cells

Thumbnail

G-CSF effects on left ventricular function assessed with standard echocardiographic evaluation (biplane EF) and 2D myocardial strain in patients with STEMI and LV dysfunction

Event: ESC Congress 2017

Topic: Adjunctive medical therapy

Session: Drug treatment of acute coronary syndrome patients

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb